At the recent Galien Forum in New York City, Merck's Chief Medical Officer Michael Rosenblatt moderated a panel discussion, "Alzheimer's Innovation and the White House 2025 Mandate: What Will It Take to Find a Treatment?"
The panel included leaders from government, industry and patient advocacy organizations who discussed Alzheimer's disease, the quest to develop medicines that may help address it, and the impact of Alzheimer's disease from a number of perspectives: personal, medical, societal and economic.
Watch the videos to see what the experts are saying.
To view the full video, click on the Chapter 1 thumbnail. Or, if you'd like to jump to a particular chapter, click on the thumbnail to begin watching the video from that point forward.